Home > All Pet Supplies >
Nobivac Feline 1-HCPCh (Eclipse 4)
Item #: 30152-415
Availability: In Stock
Usually ships In 1-2 Business Days
Vaccines are non-returnable.
- Nobivac® Feline 1-HCPCh (Eclipse 4) prevents Feline Rhinotracheitis, Calici, and Panleukopenia – Modified live virus
- Chlamydia Psittaci – Modified live bacteria
- Injectable vaccination
- For healthy cats nine weeks of age or older
- Optimal for healthy outdoor cats or cats that board frequently
Vaccines with live viruses cannot be shipped to Minnesota without a valid prescription. Please see our
for ordering information.
Nobivac® Feline 1-HCPCh (Eclipse 4) is recommended for the vaccination of healthy cats against diseases caused by feline Rhinotracheitis (feline Herpes), Calici, Panleukopenia, and Chlamydia Psittaci. Has been shown to block the replication of canine Parvovirus in cats. This vaccine goes beyond the core antigen protection to help prevent feline Chlamydophila infection. Optimal for healthy outdoor cats or cats that board frequently. Non-adjuvanted formula. Modified live viruses and bacteria. Recommended for use in healthy cats nine weeks of age or older.
For animal use only.
Store at 2 to 7° C. Do not freeze.
Do not mix with other vaccines.
Use new, non-chemically sterilized needles and syringes.
Burn vaccine container and all unused contents.
- Vaccinate healthy cats 9 weeks of age or older.
- Transfer contents of the diluent vial to the Nobivac® Feline 1-HCPCh vial aseptically.
- Mix gently until dissolved. Use entire contents immediately after rehydration.
- Two doses are required for primary immunization.
- Initial vaccination: Inject 1 dose (1 ml) subcutaneously or intramuscularly at 9 weeks of age or older
- Second vaccination: Inject 1 dose (1 ml) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.
- Annual revaccination with one dose is recommended.
- Contains gentamicin as a preservative
- Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.
- Do not vaccinate pregnant cats
- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.